Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Deal Watch: Novartis Acquires Gene Therapy Candidate From AvroBio

May 24 2023

• By Joseph Haas

Deal Watch 2021 — • Source: Shutterstock

Related Content

Alvotech Links Up With Polifarma On Proposed Eylea Biosimilar

May 12 2023

Sanofi ThiNKs Scribe’s CRISPR Approach Can Advance Its NK Cell Therapy Goals

Sep 27 2022

Deal Watch: Roche Partners With Dyno On AAV-Delivered Gene Therapies

Oct 14 2020

Building On Successes During Turbulent Times, SR One Closes $600m Fund II

Mar 27 2023

Ironwood Paying $1bn For VectivBio To Extend Its GI Franchise Beyond Linzess

May 22 2023

Back From The Dead Biodexa Makes Bid For VarianBio

May 19 2023

FTC’s Challenge Of Amgen/Horizon Merger Seeks To Fight Pharma Rebating Practices

May 16 2023

Gilead Adds Inflammation Targets To Its 2020 R&D Collaboration With Arcus

May 15 2023

Finance Watch: $1.32bn In New Biopharma VC Financings As Year-End Approaches

Dec 09 2022

Related Companies

Alimera Sciences Inc.

EyePoint Pharmaceuticals, Inc.

Ocumension Therapeutics

Scribe Therapeutics, Inc.

Prevail Therapeutics Inc.

Eli Lilly and Company

Biogen, Inc.

Sanofi

Chinook Therapeutics, Inc.

Ionis Pharmaceuticals, Inc.

SonoThera, Inc.

Janssen Pharmaceutical Cos.

AstraZeneca PLC

Revvity Inc.

Melinta Therapeutics, Inc.

Xediton Pharmaceuticals, inc.

Juno Pharmaceuticals Corporation

Omega Laboratories Ltd.

Boehringer Ingelheim GmbH

Kinoxis Therapeutics Pty Ltd

Novartis AG

AVROBIO, Inc.

Additional Topics

Business Strategies Deals M & A Commercial Deal Watch BioPharmaceutical

More from Deal Watch

More from Deals

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window